Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effect
- 1 May 2009
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 277 (2), 212-217
- https://doi.org/10.1016/j.canlet.2008.12.012
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaBlood, 2008
- Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF‐ and VEGF‐induced proliferation of human endothelial cellsJournal of Cellular Biochemistry, 2005
- Arsenic Trioxide Enhances Radiation Response of 9L Glioma in the Rat BrainRadiation Research, 2003
- Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3)FEBS Letters, 2002
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid TumorsNeoplasia, 2000
- Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable ConcentrationsJNCI Journal of the National Cancer Institute, 1999
- Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox SystemBlood, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998